会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • Cochlear Electrode With Apical Lateral Wall Section and Basal Modiolar Hugging Section
    • 耳蜗电极与顶端侧壁部分和基底Modiolar拥抱部分
    • US20150148736A1
    • 2015-05-28
    • US14609590
    • 2015-01-30
    • MED-EL Elektromedizinische Geraete GmbH
    • Claude JollyAnandhan Dhanasingh
    • A61N1/05A61M31/00
    • A61N1/0541A61M31/002
    • An implantable electrode array for a cochlear implant has an array trunk that extends along a center axis from an insertion opening in an outer surface of a patient cochlea into the scala tympani. An apical section extends along the center axis from a distal end of the array trunk and a basal branch is separate from the array trunk and extends back from the distal end of the array trunk towards the insertion opening. The apical section follows along an outer lateral wall of the scala tympani during surgical insertion to attain a final insertion position towards the outer lateral wall in an apical portion of the scala tympani beyond a first basal turn of the cochlea. The basal branch attains a final insertion position towards an inner modiolar wall by the first basal turn of the cochlea with the basal branch stimulation contacts facing the inner modiolar wall.
    • 用于耳蜗植入物的可植入电极阵列具有阵列躯干,其沿着中心轴线从患者耳蜗的外表面中的插入孔延伸到鼓风鼓中。 顶端部分沿着中心轴线从阵列干线的远端延伸,并且基部分支与阵列干线分离并且从阵列干线的远端朝向插入开口向后延伸。 顶端部分沿着外科手术插入期间的鼓风鼓的外侧壁,以在超过耳蜗的第一基底转弯之后达到鼓风鼓的顶端部分中的外侧壁的最终插入位置。 基部分支通过耳蜗的第一基底转向到达内模块壁的最终插入位置,而基部分支刺激触点面向内模块壁。
    • 8. 发明申请
    • Accessory Device for Inner Ear Drug Delivery
    • 内耳药物输送配件
    • US20130245569A1
    • 2013-09-19
    • US13784973
    • 2013-03-05
    • MED-EL ELEKTROMEDIZINISCHE GERAETE GMBH
    • Claude JollyAnandhan DhanasinghPavel MistrikSoeren SchilpRoland HesslerKenneth Mugridge
    • A61M31/00A61F11/00
    • A61M31/00A61F11/00A61F11/004A61M31/002A61N1/0541
    • An implantable drug delivery accessory is described. A middle ear guide member has a hollow interior enclosed by a non-permeable outer surface. A proximal end of the middle ear guide member is fixed to the tympanic membrane of an implanted patient. A distal end of the middle ear guide member penetrates through a fluid-tight sealed opening into the inner ear. An inner ear holding member has a proximal end connected to the distal end of the middle ear guide member at the sealed opening and a closed distal end terminating the inner ear holding member some predetermined distance within the cochlea. A hollow interior of the inner ear holding member contains a replaceable drug delivery member which stores a therapeutic drug. A semi-permeable outer surface of the inner ear holding member is connected to a cochlear implant electrode and adapted to release therapeutic drug from the hollow interior into adjacent tissue. The drug delivery member is removable and replaceable via the ear canal of the implanted patient through the proximal end of the middle ear.
    • 描述了可植入药物递送附件。 中耳引导构件具有由不可渗透的外表面封闭的中空内部。 中耳引导构件的近端固定在植入患者的鼓膜上。 中耳引导构件的远端穿过流体密封的密封开口进入内耳。 内耳保持构件具有在密封开口处连接到中耳引导构件的远端的近端,并且封闭的远端终止内耳保持构件在耳蜗内部预定距离。 内耳保持构件的中空内部包含存储治疗药物的可替换药物递送构件。 内耳保持构件的半透性外表面连接到耳蜗植入电极并且适于将治疗药物从中空内部释放到相邻组织中。 药物递送部件可通过植入患者的耳道通过中耳的近端移除和更换。